Lifeway Foods, Inc. Announces Results for the Third Quarter Ended September 30, 2017

Date : 11/14/2017 @ 6:32PM
Source : GlobeNewswire Inc.
Stock : Lifeway Foods, Inc. (MM) (LWAY)
Quote : 10.0  -0.2 (-1.96%) @ 12:02PM

Lifeway Foods, Inc. Announces Results for the Third Quarter Ended September 30, 2017

Lifeway (NASDAQ:LWAY)
Historical Stock Chart

1 Month : From Oct 2017 to Nov 2017

Click Here for more Lifeway Charts.

Lifeway Foods, Inc. (Nasdaq:LWAY), the leading U.S. supplier of kefir cultured dairy products, today reported financial results for the third quarter ended September 30, 2017.

“Overall, Lifeway performed well in what continues to be a challenging business climate,” said CEO Julie Smolyansky. “While sales declined 4% in the quarter, we continue to shape our product offering responsive to today’s consumer and invest in organizational capabilities that enable our strategic framework. In addition to the changes we implemented in our sales organization earlier in the year, our innovation and commercialization teams have been delivering new, on-trend solutions both inside and outside of dairy. As I look forward to 2018 and beyond, I remain confident that our team will drive profitable growth from both our flagship drinkable kefir business and our category-expanding innovation.”

Third Quarter Results

Third quarter net sales decreased by $1,204 or 4.0% to $28,786. Lower volumes of our branded drinkable kefir were partially offset by the incremental impact of our new cupped kefir product line, an increase in the volume of our private label products and lower trade promotion.

Gross profit as a percent of net sales increased to 27.2% during the three-month period ended September 30, 2017 from 26.6% during the same three-month period in 2016. The higher gross profit percent reflects lower delivery costs and reduced trade promotion partially offset by the deleveraging impact of lower net sales relative to fixed costs.

Selling expenses decreased by $296 or 6.9% to $4,010 during the three-month period ended September 30, 2017 from $4,306 during the same period in 2016. The decline in selling expenses was driven by lower advertising costs and partially offset by higher sales salaries. We lowered our advertising costs through lower production costs of our Probiotic Billionaire campaign in the third quarter compared to the production costs of the campaign we ran in the year ago period. The higher sales salaries reflect our strategic initiative launched in the first quarter of 2017 to elevate customer focus and improve selling effectiveness with an augmented in-house sales team.  Selling expenses as a percentage of net sales were 13.9% for the three-month period ended September 30, 2017 compared to 14.4% for the same period in 2016.

General and administrative expenses decreased $163 or 4.9% to $3,145 during the three-month period ended September 30, 2017 from $3,308 during the same period in 2016. The decrease is primarily a result of lower professional fees.

Our effective tax rate for the three months ended September 30, 2017 was 41.9% compared to an effective tax rate that exceeded 100% in the same period last year. We reported net income of $243 or $0.02 per basic and diluted common share for the three-month period ended September 30, 2017 compared to a net loss of $64 or $0.00 per basic and diluted common share in the same period in 2016.

First Nine Months of Fiscal 2017

Year to date net sales decreased by $1,055 or 1.1% to $92,636 during the nine-month period ended September 30, 2017 from $93,691 during the same nine-month period in 2016.  Lower volumes of our branded drinkable kefir were partially offset by the incremental impact of our new cupped kefir product line and an increase in the volume of our private label products.

Gross profit as a percent of net sales decreased to 27.6% from 28.2% in the same period last year.  The lower gross profit percent reflects higher milk costs and increased trade promotion partially offset by lower delivery costs.

Selling expenses increased by $915 or 8.5% to $11,648 during the first nine months of 2017 from $10,733 in the first nine months of 2016 reflecting higher sales salaries partially offset by lower advertising costs.  As a percentage of net sales, selling expenses increased to 12.6% compared to 11.5% in the same period last year.

General and administrative expenses increased $443 or 4.3% to $10,743 during the nine-month period ended September 30, 2017 from $10,300 during the same period in 2016. The increase reflects higher compensation expense driven by increased headcount and incentive compensation partially offset by lower professional fees.

Our effective tax rate for the nine months ended September 30, 2017 was 42.9% compared to an effective tax rate of 33.0% in the same period last year. We reported net income of $1,403 or $0.09 per basic and diluted common share for the nine-month period ended September 30, 2017 compared to net income of $2,998 or $0.19 per basic and diluted common share in the same period in 2016.

Balance Sheet

Cash and cash equivalents decreased $1.5 million to $7.3 million during the nine months ended September 30, 2017. As of September 30, 2017, the Company had outstanding borrowings of approximately $6.5 million, of which $3.3 million becomes due in May of 2018. The Company had additional borrowing capacity of $5 million under its line of credit as of September 30, 2017.

Share Repurchase Program

On September 24, 2015, the Company's Board of Directors authorized a stock repurchase program (the “2015 stock repurchase program”) under which the Company may, from time to time, repurchase shares of its common stock for an aggregate purchase price not to exceed the lesser of $3,500 or 250 shares. On November 1, 2017, the Company’s Board of Directors amended the Company’s 2015 stock repurchase program (the “2017 amendment”), by increasing the authorization to the lesser of $5,185 or 625 shares, exclusive of the shares previously authorized under the 2015 stock repurchase program.  The repurchase program does not obligate the Company to purchase any shares, and the program may be terminated, suspended, increased, or decreased by the Company’s Board of Directors in its discretion at any time.

About Lifeway Foods, Inc.

Lifeway Foods, Inc. (LWAY), recently named one of Forbes’ Best Small Companies, is America’s leading supplier of the probiotic, fermented beverage known as kefir. In addition to its line of drinkable kefir, the company also produces frozen kefir, specialty cheeses and a ProBugs line for kids. Lifeway’s tart and tangy cultured dairy products are available throughout the United States and on a small, but growing basis in Canada, Latin America, Ireland, and the United Kingdom. Learn how Lifeway is good for more than just you at www.lifewaykefir.com.

Forward-Looking Statements

All statements in this release (and oral statements made regarding the subjects of this release) contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, future operating and financial performance, product development, market position, business strategy and objectives. These statements use words, and variations of words, such as “will,” “invest,” “drive,” “confident,” “forward,” “innovate,”  “continue,” “expand,” and “grow.” Other examples of forward looking statements may include, but are not limited to, (i) statements of Company plans and objectives, including the introduction of new products, or estimates or predictions of actions by customers or suppliers, (ii) statements of future economic performance, and (III) statements of assumptions underlying other statements and statements about Lifeway or its business. You are cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events and thus are inherently subject to uncertainty. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from Lifeway’s expectations and projections. These risks, uncertainties, and other factors include: price competition; the decisions of customers or consumers; the actions of competitors; changes in the pricing of commodities; the effects of government regulation; possible delays in the introduction of new products; and customer acceptance of products and services. A further list and description of these risks, uncertainties, and other factors can be found in Lifeway’s Annual Report on Form 10-K for the fiscal year ended December 31, 2016, and the Company’s subsequent filings with the SEC. Copies of these filings are available online at https://www.sec.gov, http://lifewaykefir.com/investor-relations/, or on request from Lifeway. Information in this release is as of the dates and time periods indicated herein, and Lifeway does not undertake to update any of the information contained in these materials, except as required by law. Accordingly, YOU SHOULD NOT RELY ON THE ACCURACY OF ANY OF THE STATEMENTS OR OTHER INFORMATION CONTAINED IN ANY ARCHIVED PRESS RELEASE.

Contact:

Lifeway Foods, Inc.Phone: 847-967-1010Email: info@Lifeway.net

LIFEWAY FOODS, INC. AND SUBSIDIARIES
Consolidated Balance Sheets
September 30, 2017 and December 31, 2016
(In thousands)
    
  
 September 30, 2017 (Unaudited) December 31, 2016
Current assets   
Cash and cash equivalents  7,264    8,812 
Accounts receivable, net of allowance for doubtful accounts and    
discounts and allowances of $1,160 and $1,600 at September 30, 2017 and   
December 31, 2016 respectively  10,408    9,594 
Inventories, net  8,050    8,042 
Prepaid expenses and other current assets  1,016    785 
Refundable income taxes  771    309 
Total current assets  27,509     27,542  
    
Property, plant and equipment, net  23,888     21,832  
    
Intangible assets   
Goodwill and other indefinite-lived intangibles  14,068    14,068 
Other intangible assets, net  1,143    1,647 
Total intangible assets  15,211     15,715  
    
Other Assets  150    125 
Total assets  66,758     65,214  
    
Current liabilities   
Current maturities of notes payable  3,292    840 
Accounts payable  7,104    5,718 
Accrued expenses  2,866    2,169 
Accrued income taxes  74    654 
Total current liabilities  13,336     9,381  
    
Notes payable  3,197     6,279  
Deferred income taxes, net  1,192     1,192  
Other long-term liabilities  406     -   
Total liabilities  18,131     16,852  
    
Stockholders' equity   
Common stock, no par value; 40,000,000 shares authorized; 17,274 shares   
  issued; 16,037 and 16,154 outstanding at September 30, 2017 and   
  December 31, 2016, respectively  6,509    6,509 
Paid-in-capital  2,247    2,198 
Treasury stock, at cost  (11,527)   (10,340)
Retained earnings  51,398    49,995 
Total stockholders' equity  48,627     48,362  
    
Total liabilities and stockholders' equity  66,758     65,214  

 

LIFEWAY FOODS, INC. AND SUBSIDIARIES  
Consolidated Statements of Income (Loss) and Comprehensive Income (Loss)  
For the three and nine months ended September 30, 2017 and 2016  
(Unaudited)  
(In thousands, except per share data)  
          
 Three Months Ended September 30, Nine Months Ended September 30,  
  2017   2016   2017   2016   
          
Net sales$   28,786   $   29,990   $   92,636   $   93,691    
          
Cost of goods sold   20,331     21,478     65,262     65,480   
Depreciation expense   618     533     1,801     1,797   
Total cost of goods sold   20,949     22,011     67,063     67,277   
          
Gross profit   7,837      7,979      25,573      26,414    
          
Selling expense   4,010     4,306     11,648     10,733   
General and administrative expense   3,145     3,308     10,743     10,300   
Amortization expense   168     176     504     529   
Total operating expenses   7,323      7,790      22,895      21,562    
          
Income from operations   514      189      2,678      4,852    
          
Other income (expense):         
Interest expense   (62)    (56)    (180)    (161)  
Loss on sale of investments, net reclassified from OCI   -      12     -      (15)  
Loss on sale of equipment   (34)    (156)    (39)    (307)  
Other income, net   -      28     -      105   
Total other income (expense)   (96)    (172)    (219)    (378)  
          
Income before provision for income taxes   418      17      2,459      4,474    
          
Provision for income taxes   175     81     1,056     1,476   
          
Net income (loss)$   243   $   (64) $   1,403   $   2,998    
          
Earnings per common share:         
  Basic$  0.02  $  (0.00) $  0.09  $  0.19   
  Diluted$  0.02  $  (0.00) $  0.09  $  0.19   
          
Weighted average common shares:         
  Basic 16,093   16,141   16,133   16,159   
  Diluted 16,168   16,161   16,218   16,181   
          
          
COMPREHENSIVE INCOME (LOSS)         
Net income (loss)$   243   $   (64) $   1,403   $   2,998    
  Other comprehensive income (loss), net of tax:         
  Unrealized gains on investments, net of taxes   -      6     -      62   
  Reclassifications to earnings:         
  Realized (gains) losses on investments, net of taxes   -      (8)    -      9   
Comprehensive income (loss)$   243   $   (66) $   1,403   $   3,069    
          

 

LIFEWAY FOODS, INC. AND SUBSIDIARIES
Consolidated Statements of Cash Flows
For the nine months ended September 30, 2017 and 2016
(Unaudited)
(In thousands)
    
  2017   2016 
Cash flows from operating activities:   
Net Income   1,403     2,998 
Adjustments to reconcile net income to operating cash flow:   
Depreciation and amortization   2,305     2,326 
Loss on sale of investments, net   -      15 
Reserve for inventory obsolescence   320     89 
Stock-based compensation   901     100 
Deferred income taxes   -      444 
Loss on sale of property and equipment   39     307 
(Increase) decrease in operating assets:   
Accounts receivable   (814)    (823)
Inventories   (328)    (1,611)
Refundable income taxes   (462)    (72)
Prepaid expenses and other current assets   (231)    (310)
Increase (decrease) in operating liabilities:   
Accounts payable   1,384     370 
Accrued expenses   252     465 
Accrued income taxes   (580)    215 
Net cash provided by operating activities   4,189      4,513  
    
Cash flows from investing activities:   
Purchases of investments   (25)    (559)
Proceeds from sale of investments   -      2,751 
Redemption of certificates of deposits   -      513 
Purchases of property and equipment   (3,932)    (2,481)
Proceeds from sale of property and equipment   37     149 
Net cash (used in) provided by investing activities   (3,920)    373  
    
Cash flows from financing activities:   
Purchase of treasury stock   (1,187)    (738)
Repayment of notes payable   (630)    (630)
Net cash used in financing activities   (1,817)    (1,368)
    
Net (decrease) increase in cash and cash equivalents   (1,548)    3,518  
    
Cash and cash equivalents at the beginning of the period   8,812     5,646 
    
Cash and cash equivalents at the end of the period$   7,264   $   9,164  
    
Supplemental cash flow information:   
Cash paid for income taxes, net of refunds$  2,098  $  886 
Cash paid for interest$  180  $  162 
    

 

Latest LWAY Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.